GlaxoSmithKline (Spain)

GlaxoSmithKline (Spain)

GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for GlaxoSmithKline (Spain), Spain, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

56%


Total
Publications

826


Total Open
Publications

462


Total
Citations

27K


Open Access
Percentage

56%


Total
Publications

826


Total Open
Publications

462


Total
Citations

27K

Wikipedia

Website

download

Breakdown

16% 31% 8% 45%

Publisher Open

16%

Both

31%

Other Platform Open

8%

Closed

45%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035404550556065Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

53%OA Journal

OA Journal 53%

203

Hybrid 26%

99

No Guarantees 21%

79

Other Platform Open

Domain 80%

266

Institution 44%

146

Other Internet 16%

53

Public 5%

17

Preprint 0%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
265
DOI
Other Internet
44
Carlos III University of Madrid - e-Archivo
Institution
24
University of Dundee - Discovery Research Portal
Institution
23
Europe PMC
Domain
23
Unknown Repository
Other Internet
15
Figshare
Public
14
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
11
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
10
University of Melbourne - Minerva Access
Institution
9
1 / 7

Data updated 18 August 2025

Share

Share

Share